In this review:
- Telehealth vs in-person care in T1D: an open label RCT
- Continuous glucose monitoring identifies dysglycaemia in very young children at risk of T1D
- Empagliflozin and cardiac function in T2D without heart disease: the EMPA-HEART trial
- Tirzepatide induces weight loss in T2D regardless of BMI: post hoc analysis of SURPASS 1-5
- Physical activity and severe hypoglycaemia in T1D
- Dishabituation with high intensity exercise improves responses to hypoglycaemia in T1D in patients with impaired awareness of hypoglycaemia
- An oxygenated hydrogel enhanced the survival of human islets within macroencapsulation devices
- Hypoglycaemia increases during pregnancy after gastric bypass: the BAMBI study
- Cardiorenal and safety outcomes with finerenone in T2D with CKD and obesity
Please login below to download this issue (PDF)